Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA "National Security" Mission: Counterfeiting And Bioterrorism?

This article was originally published in The Tan Sheet

Executive Summary

FDA should heighten its focus on product security to ensure counterfeiting does not take place, not only for consumer safety, but to cut off a source of income for terrorists, asserted House Energy & Commerce Committee Senior Counsel Alan Slobodin.

You may also be interested in...



Infant formula counterfeits & terrorism

FDA recently "became aware of infant formula that was tampered with that was used to fund al Quaeda operatives," FDA Associate Commissioner for Regulatory Affairs Steven Niedelman said at the Food & Drug Law Institute's Enforcement & Litigation Conference in Washington D.C. Sept. 23. "Terrorism has become a big issue for the agency and one that all firms need to take into account," he noted. House Energy & Commerce Committee Senior Counsel Alan Slobodin asserted two years ago that terrorist organizations often are financed through counterfeit trade of consumer products such as infant formula (1"The Tan Sheet" Oct. 8, 2001, In Brief)...

Infant formula counterfeits & terrorism

FDA recently "became aware of infant formula that was tampered with that was used to fund al Quaeda operatives," FDA Associate Commissioner for Regulatory Affairs Steven Niedelman said at the Food & Drug Law Institute's Enforcement & Litigation Conference in Washington D.C. Sept. 23. "Terrorism has become a big issue for the agency and one that all firms need to take into account," he noted. House Energy & Commerce Committee Senior Counsel Alan Slobodin asserted two years ago that terrorist organizations often are financed through counterfeit trade of consumer products such as infant formula (1"The Tan Sheet" Oct. 8, 2001, In Brief)...

Infant formula counterfeits & terrorism

FDA recently "became aware of infant formula that was tampered with that was used to fund al Quaeda operatives," FDA Associate Commissioner for Regulatory Affairs Steven Niedelman said at the Food & Drug Law Institute's Enforcement & Litigation Conference in Washington D.C. Sept. 23. "Terrorism has become a big issue for the agency and one that all firms need to take into account," he noted. House Energy & Commerce Committee Senior Counsel Alan Slobodin asserted two years ago that terrorist organizations often are financed through counterfeit trade of consumer products such as infant formula (1"The Tan Sheet" Oct. 8, 2001, In Brief)...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel